1. Which of the following correctly prescribes collaborative prescribing?
A. Pharmacist prescribes without the supervision of a provider within the scope of their practice
B. An agreement between the patient and the pharmacist that allows prescribing with no delegation from the physician
C. A relationship between the participating patient, provider and pharmacist that limits prescribing to specific patients
D. Pharmacists prescribes under a protocol published by a state body that is the same for all qualified pharmacists
2. Which of the following is true about autonomous prescribing?
A. A pharmacist can implement a service faster
B. Autonomous prescribing can allow for a much broader type of practice
C. Leads to inconsistencies of service across the state
D. Autonomous prescribers must have a diagnosis before prescribing
3. Which of the following is the correct sequence of steps for effective prescribing?
A. Define problem, consider pathophysiology, select therapeutic objective, select drug of choice, determine dosage regimen, develop monitoring plan, plan patient education
B. Define problem, select therapeutic objective, consider pathophysiology, select drug of choice, determine dosage regimen, develop monitoring plan, plan patient education
C. Define problem, consider pathophysiology, select therapeutic objective, select drug of choice, determine dosage regimen, plan patient education, develop monitoring plan
D. Define problem, consider pathophysiology, select therapeutic objective, develop monitoring plan, select drug of choice, determine dosage regimen, plan patient education
4. Which of the following questions should a pharmacist consider when determining the appropriate dosing regimen?
A. Is the dosage form suitable for the patient?
B. Is the dosage schedule suitable for the patient?
C. Is the duration of treatment suitable?
D. All the above
5. Which of the following correctly defines a recommendation grade of 1A?
A. Recommendation can apply to most patients in certain circumstances, but higher quality research is likely to have an important impact on the estimate of effect and may change the estimate
B. Recommendation can apply to most patients in certain circumstances and further research is very unlikely to change confidence in the estimate of effect
C. Uncertainty in the estimates of benefits, risks and burdens
D. Benefits closely balanced with risks and burdens but there is some uncertainty in the estimate
6. Which correctly defines surrogate markers in clinical trials?
A. They measure the outcomes the investigators want to study
B. They are used to determine whether benefits outweigh the risks of the drug therapy
C. They measure a parameter that describes quality and quantity of life
D. They are used when the clinical outcomes take a very long time to study
7. Which of the following must be proven to support a cause of action in negligence?
A. A duty must exist
B. A breach of duty of due care
C. Causation of harm or injury
D. All the above must be proven
8. Which of the following correctly defines risk prevention/modification?
A. A pharmacist researches and writes a policy for prescribing stroke medications
B. A pharmacist enters a CPA with a neurologist
C. A pharmacist decides not to prescribe for stroke patients
D. None of the above
9. Which of the following correctly defines liability insurance your employer would carry?
A. Insurance for protecting the property of any business entity
B. Insurance for protecting the physical assets of any business entity
C. Insurance that will cover the cost of removing property to protect it from further harm
D. Insurance that covers any damage or injury involved in a negligence suit
10. Which of the following is true about individual professional liability insurance?
A. You are not legally permitted to purchase individual professional liability insurance if your employer has liability insurance
B. It is illegal for a defense team representing the employer to claim the employee violated company policy thereby the employer must always protect the employee
C. Your own professional liability insurance will cover you if you practice outside of your workplace
D. Only consider individual professional liability insurance if you will be prescribing
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Will the information presented cause you to change your practice?
A. Yes
B. No
24. Are you committed to making these changes?
A. Yes
B. No
25. As a result of this activity, did you learn something new?
A. Yes
B. No
26. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
27. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20